Brand Awareness Archives - Page 19 of 41

TuesdayNov 10, 2020 9:00 am

On the Trail of Better Therapeutics for Depression

NetworkNewsWire Editorial Coverage: Big pharma and life science companies are making big news these days. The drug-development space is seeing strong investor interest as these companies make breakthrough advancements that address vast unmet medical needs. Strategic M&A moves are adding spice to the gumbo for investors as pioneering research remains focused on providing life-changing treatments for those suffering from a myriad of disorders. One of the largest and trickiest medical disorders of mankind may be on the cusp of more effective treatment. Depression is often kept in the dark and not talked about, but it is estimated that more than…

ThursdayOct 22, 2020 9:00 am

In Pursuit of the Elusive Drug — the Billion-Dollar Blockbuster

NetworkNewsWire Editorial Coverage: Enormous amounts of money exchange hands in the big pharma space as companies merge and are acquired — all in search of the next blockbuster drug. While the discovery of a blockbuster drug, or a drug that generates more than $1 billion in sales per year, occurs rarely, the tremendous benefits of owning blockbuster therapeutics can mean tens of billions of dollars for a company during the patent-protected life of the drug. It makes sense, then, that pharmaceutical giants are in hot pursuit of what could be the next new drug — and the company that owns…

TuesdayOct 20, 2020 9:00 am

Banking on the Next Blockbuster Drug

NetworkNewsWire Editorial Coverage: Pharmaceutical companies invest enormous amounts of time and money on the research and development of new drugs, typically years in the making and costing millions of dollars. Only occasionally is a new drug developed that’s approved and generates more than $1 billion per year in sales, a benchmark in the industry commonly called a “blockbuster.” Blockbusters are scarce, but the proverbial quest for blockbuster drugs continues unabated because of vast unmet medical needs and because blockbuster therapeutics can be worth tens of billions of dollars during their patent-protected lives. Little wonder that pharmaceutical giants often buy up…

ThursdayOct 15, 2020 9:00 am

SPACs Surge as Biotech Booms

NetworkNewsWire Editorial Coverage: As the world has focused on the search for COVID vaccines and therapeutics, biotech IPOs have quietly gone bonkers. As a matter of fact, 2020 is on track to post the highest number of biotech IPOs in over five years. Along the way, biotech companies have managed to raise a lot of capital already this year. As biotech demand has surged, so has the number of biotech-focused SPACs (Special Purpose Acquisition Company). A SPAC is a company that raises capital through an IPO with the sole intent of buying or merging with another operating company. SPACs have…

WednesdayOct 14, 2020 9:00 am

Multi-Billion-Dollar Market Forecast in Psychedelic Therapeutics

NetworkNewsWire Editorial Coverage: Compelling evidence of the therapeutic benefits of psychedelic drugs appears in multiple scientific studies. Several clinical trials are underway in the United States and worldwide to investigate the therapeutic effects of psilocybin, the active component in the fungi known colloquially as "magic mushrooms." There is new hope for treating such debilitating disorders as depression, anxiety, post-traumatic stress disorder, anorexia, obsessive-compulsive disorder, and addiction. With more than $6.8 billion on the line by 2027, companies at the vanguard of the psychedelic therapeutic drug market could reap enormous benefits in the coming years. Some of these companies, such as…

TuesdayOct 13, 2020 9:00 am

Blockbuster Year and Bright Horizons for SPACs

NetworkNewsWire Editorial Coverage: The year 2020 has already seen 127 SPAC IPOs, which have collectively raised over $48.5 billion in proceeds — more than the past ten years combined. A special purpose acquisition company (SPAC) is essentially a blank-check company formed to raise capital through an IPO with the sole intent of buying or merging with another operating company. SPACs have evolved to become an expedited and cost-effective way of doing an M&A deal and have been utilized by multiple Wall Street heavyweights. Going public via a SPAC enables a company to get a deal done in weeks instead of…

FridayOct 02, 2020 9:00 am

Life-Saving Advancements, Treatments Delivered by Companies Invested in Innovation

NetworkNewsWire Editorial Coverage: Innovation and breakthroughs in the biotech industry are essential to identifying and providing life-saving treatments. Companies that invest substantial amounts of time, effort, and resources in key areas of research and innovation are critical in the advancement treatment options across the board. On the front lines of research and development in the area of inflammation, which typically occurs in the body as a natural response to threats such as infection or injury can cause severe damage and even death, is 180 Life Sciences Corp. (NASDAQ: KBLM) (NASDAQ: KNLMR) (NASDAQ: KBLMW) (180 Profile). The company is focused on…

ThursdayOct 01, 2020 9:00 am

New Products, Programs in Smoking Cessation Sector Offer Hope, Support to Those Desperate to Quit

NetworkNewsWire Editorial Coverage: Smoking is the leading cause of preventable death in the world today. Globally, 7 million people die every year from tobacco use, and the number is projected to increase to 8 million if the pattern of smoking doesn’t change. These disturbing statistics are being noted by companies with experience and interest in working to make a difference in the world and provide effective ways to support and help smokers quit. One of those companies, Kaival Brands Innovations Group Inc. (OTCQB: KAVL) (KAVL Profile), recently announced it had acquired a patent for a synthetic nicotine and synthetic nicotine…

WednesdaySep 30, 2020 9:00 am

Solving One of the Largest Drivers of Disease: Inflammation

NetworkNewsWire Editorial Coverage: Inflammation typically occurs in the body as a natural response to threats such as infection or injury, but chronic inflammation can cause severe damage and even death. Inflammation is a well-known symptom of multiple infectious diseases. However, multidiscipline research strongly suggests that inflammation is also closely linked with a broad range of noninfectious diseases. The critical aspects of the interplay between inflammation and disease may well be the key to development of a new generation of drugs to treat previously untreatable diseases, sparking a flurry of biotech research and development in the field. At the vanguard of…

TuesdaySep 29, 2020 9:00 am

Desperate Need Fuels New Products, Programs in Smoking Cessation Space

NetworkNewsWire Editorial Coverage: Approximately 1,300 people die every day as a result of smoking, and more than 16 million Americans are living with a disease caused by smoking. These alarming numbers aren’t going unnoticed, and companies with expertise in the space are seizing the opportunity to provide solutions designed to help smokers kick the habit. One of those companies, Kaival Brands Innovations Group Inc. (OTCQB: KAVL) (KAVL Profile), has just acquired a patent covering the creation of all synthetic nicotine smoking cessation and synthetic nicotine addiction therapy products; the company is also creating a subsidiary that will own the patent…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Category: Brand Awareness